Many breast cancer survivors report cognitive problems following treatment. New research from UCSD finds breast cancer survivors who increase physical activity and embark on regular exercise experience improved mental processing.
A new study reports inflammation in the blood may play a role in cognitive problems following chemotherapy. Researchers report identifying the inflammatory biomarkers and reducing inflammation may prevent some of the symptoms of chemo brain.
A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories.
A new study suggests blocking estrogen may help preserve eyesight in girls with NF1.
Researchers report on how exosomic miRNAs released within a tumor environment affect resistance to chemotherapy.
Researchers have developed a new approach that uses microRNA in combination with chemotherapy to help treat glioblastoma brain cancer. In preclinical models, the approach increases survival of the deadly brain cancer five fold.
A new study provides a possible explanation as to what causes cognitive and memory problems associated with chemotherapy treatments.
Researchers report children who received chemotherapy alone for acute lymphoblastic leukemia remain at risk for attention and learning problems after the treatment ends.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Researchers discovered a mutant form of Chk1 gene that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs. This study illustrates an unprecedented finding, that artificially activating Chk1 alone is sufficient to kill cancer cells.
Researchers have successfully bypassed the blood-brain barrier using a laser probe to help deliver chemotherapy drugs to glioblastoma patients.
Researchers report improved survival rates in people who received chemotherapy postoperatively for medulloblastoma brain cancer.
